Quick Answer
Regencell Bioscience Holdings Ltd reported Earnings Per Share Diluted of $0.72 (loss) per share for the year ending 2025.
- Regencell Bioscience Holdings Ltd showed an increase of +17.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Regencell Bioscience Holdings Ltd's annual report (Form 10-K), filed with the SEC on October 31, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Regencell Bioscience Holdings Ltd's Earnings Per Share Diluted has declined by 800.0%.
- Historical annual values: Fiscal year 2025: $0.72 (loss) per share | Fiscal year 2024: $0.87 (loss) per share | Fiscal year 2023: $1.19 (loss) per share | Fiscal year 2022: $0.58 (loss) per share | Fiscal year 2021: $0.13 (loss) per share | Fiscal year 2020: $0.08 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: